Pharmaceutical Care of Canines: Practitioner Summary
Pharmaceutical Care of Canines |
||
Disease State |
Clinical Pearls |
|
Hypothyroidism |
|
|
Hyperadrenocorticism (Cushing’s Disease) |
|
|
Hypoadrenocorticism (Addison’s Disease) |
|
|
Diabetes Mellitus |
|
|
Idiopathic Epilepsy |
|
|
Cardiovascular |
|
|
Pain |
|
|
Urinary Incontinence |
|
|
Dermatological |
|
|
Infectious Disease |
|
References:
- Food and Drug Administrastion Center for Veterinary Medicine. Vetoryl (trilostane) capsules letter-pharmacist. September 11, 2009. https://www.avma.org/sites/default/files/resources/fda_vetoryl_pharm_Itr.pdf. Accessed June 1, 2021.
- Cook AK, Nieuwoudt CD, Longhofer SL. Pharmaceutical Evaluation of Compounded Trilostane Products. J Am Anim Hosp Assoc. 2012;48(4):228-233.
- Charalambous M, Bhatti SFM, Van Ham L, et al. Intranasal midazolam versus rectal diazepam for management of canine status epilepticus: a multicenter randomized parallel-group clinical trial. J Vet Intern Med. 2017;31(4):1149-1158.
- Helms S, Fox S, Mixon W, Vail J. Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension. Int. J. Pharm. Compd. 2012;16(1):34-37.
- Galliprant [US Package insert]. In: Elanco; 2016.
- Budsberg SC, Torres BT, Kleine SA, et al. Lack of effectiveness of tramadol hydrochloride for the treatment of pain and joint dysfunction in dogs with chronic osteoarthritis. J Am Vet Med Assoc 2018;252(4):427-432.